Stock Screener App

Frei -

Installieren

Drug Manufacturers - General

101.88

0.43% -0.44

Merck Co Inc (MRK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Merck Co Inc Aktie (MRK) Neueste Nachrichten

Lowe Brockenbrough & Co. Inc. Sells 10,077 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Merck & Co., Inc. (NYSE:MRK) Q3 2024 Earnings Call Transcript - Insider Monkey

Merck & Co., Inc. (NYSE:MRK) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat

Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease - Yahoo Finance UK

Merck & Co., Inc. (NYSE:MRK) Shares Down 0.9% Following Analyst Downgrade - MarketBeat

Meitav Investment House Ltd. Sells 325,858 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Merck Animal Health unveils ALLFLEX® APR series handheld readers - www.thecattlesite.com

Merck & Co Inc (MRK) Q3 2024 Earnings Call Highlights: Strong Oncology and Animal Health ... - Yahoo Finance

Merck & Co. Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Trending : Merck & Co. Lowers 2024 Adjusted EPS Outlook - Marketscreener.com

Merck & Co., Inc. (NYSE:MRK) Trading Down 2.9%Here's Why - MarketBeat

Merck tops Q3 earnings forecasts despite slower Gardasil demand - ShareCast

Merck & Co., Inc. (NYSE:MRK) Sets New 52-Week LowShould You Sell? - MarketBeat

Merck sees Gardasil China woes carrying into 2025 - Reuters

Merck & Co Inc (MRK) Stock Price Down 3.41% on Oct 31 - GuruFocus.com

Merck & Co. (MRK) Narrows Sales Outlook With Gardasil Shot Lagging in China - Bloomberg

Merck stock on watch after Q3 results (update) (MRK:NYSE) - Seeking Alpha

Infographic: How Merck (MRK) performed in Q3 2024 - AlphaStreet

Bristol Myers Squibb stock rises, Merck moves lower. Here's why. - Yahoo Finance

Merck Lowers Full-Year Sales Guidance Despite Strong Overall Q3 Results - BioSpace

Merck & Co., Inc. (NYSE:MRK) Updates FY 2024 Earnings Guidance - MarketBeat

Merck third quarter better than expected, but Gardasil sales sag in China again - Marketscreener.com

Merck tops estimates despite muted Gardasil and diabetes drug sales - Proactive Investors Australia

Merck: adjusted net income close to $4 billion in Q3 - Marketscreener.com

Merck & Co., Inc. (NYSE:MRK) Shares Acquired by JFS Wealth Advisors LLC - MarketBeat

Merck: Q3 Earnings Snapshot - Marketscreener.com

Merck's Q3 sales up 4% to $16.7 billion - baha news

Merck Announces Third-Quarter 2024 Financial Results - Business Wire

Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch

Merck & Co., Inc. (NYSE:MRK) Trading Down 0.1%Should You Sell? - MarketBeat

Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey

SteelPeak Wealth LLC Has $7.40 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Is Eli Lilly Stock a Buy? - The Motley Fool

Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’ - Insider Monkey

Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch

Merck & Co., Inc. (NYSE:MRK) Trading Up 0.3%Here's What Happened - MarketBeat

A Look Into Merck & Co Inc's Price Over Earnings - Benzinga

China Universal Asset Management Co. Ltd. Raises Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Merck & Co. Inc. stock rises Monday, still underperforms market - MarketWatch

Merck & Co., Inc. (NYSE:MRK) Trading Up 0.2%Here's What Happened - MarketBeat

Why Is Moderna Stock Trading Higher On Monday? - Benzinga

Merck: collaboration with Moderna in lung cancer - Marketscreener.com

Nisa Investment Advisors LLC Boosts Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts - Insider Monkey

Merck & Co., Inc. (NYSE:MRK) Shares Bought by Allworth Financial LP - MarketBeat

Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024 - Insider Monkey

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Boston Trust Walden Corp - MarketBeat

Is Merck Stock Undervalued After Its Colossal Earnings Growth? - MSN

Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch

BetterInvesting™ Magazine Update on Merck (MRK) and Ball (BALL) - Marketscreener.com

Merck & Co., Inc. (NYSE:MRK) PT Lowered to $130.00 - MarketBeat

Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat (MRK) - Seeking Alpha

Merck & Co., Inc. (NYSE:MRK) Shares Down 0.4%Here's What Happened - MarketBeat

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Mediolanum International Funds Ltd Increases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Arcus Begins Differentiating Its HIF-2a inhibitor Versus Merck’s Welireg - Scrip

Merck & Co., Inc. (NYSE:MRK) Shares Down 0.2%What's Next? - MarketBeat

CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines - Benzinga

Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance - Insider Monkey

Assenagon Asset Management S.A. Buys 805,571 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Modifi acquired by Merck in $1.3B deal - BioWorld Online

Merck: EU approves two new indications for Keytruda - Marketscreener.com

NVS

$109.35

0.88%

JNJ

$160.13

0.17%

ABBV

$203.55

0.16%

AMGN

$319.22

0.29%

PFE

$28.09

0.74%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters